BSE Live
Jan 09, 16:01Prev. Close
431.65
Open Price
432.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 09, 15:59Prev. Close
432.35
Open Price
431.35
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
406.20 (5701)
| Profit & Loss account of Panacea Biotec (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| INCOME | ||||||
| Revenue From Operations [Gross] | 492.60 | 551.93 | 456.92 | 659.22 | 617.65 | |
| Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue From Operations [Net] | 492.60 | 551.93 | 456.92 | 659.22 | 617.65 | |
| Total Operating Revenues | 559.09 | 559.17 | 459.95 | 661.23 | 624.81 | |
| Other Income | 20.66 | 25.80 | 51.66 | 10.97 | 9.98 | |
| Total Revenue | 579.75 | 584.96 | 511.61 | 672.20 | 634.78 | |
| EXPENSES | ||||||
| Cost Of Materials Consumed | 214.07 | 210.46 | 211.03 | 281.25 | 167.76 | |
| Purchase Of Stock-In Trade | 7.60 | 1.80 | 7.26 | 29.93 | 31.26 | |
| Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes In Inventories Of FGWIP And Stock In Trade | -22.13 | 17.86 | 34.37 | -48.97 | 5.61 | |
| Employee Benefit Expenses | 173.05 | 149.57 | 126.48 | 182.94 | 156.17 | |
| Finance Costs | 3.88 | 3.58 | 4.44 | 180.84 | 185.34 | |
| Depreciation And Amortisation Expenses | 34.81 | 36.71 | 39.12 | 43.66 | 45.59 | |
| Other Expenses | 212.42 | 199.54 | 178.76 | 229.95 | 187.37 | |
| Total Expenses | 623.70 | 619.52 | 601.47 | 899.60 | 779.11 | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | -43.94 | -34.56 | -89.86 | -227.40 | -144.32 | |
| Exceptional Items | 35.99 | 36.03 | 102.66 | 1,676.21 | 0.00 | |
| Profit/Loss Before Tax | -7.95 | 1.48 | 12.81 | 1,448.81 | -144.32 | |
| Tax Expenses-Continued Operations | ||||||
| Current Tax | 0.01 | 0.69 | 2.56 | 400.73 | 2.32 | |
| Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax | 0.76 | 2.29 | 43.99 | -29.82 | -0.37 | |
| Other Direct Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Tax Expenses | 0.77 | 2.98 | 46.55 | 370.91 | 1.96 | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | -8.72 | -1.51 | -33.75 | 1,077.90 | -146.28 | |
| Profit/Loss From Continuing Operations | -8.72 | -1.51 | -33.75 | 1,077.90 | -146.28 | |
| Profit/Loss For The Period | -8.72 | -1.51 | -33.75 | 1,077.90 | -147.74 | |
| Minority Interest | 0.35 | 0.33 | 0.51 | -0.02 | -0.04 | |
| Consolidated Profit/Loss After MI And Associates | -8.37 | -1.17 | -33.24 | 1,077.89 | -147.70 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| EARNINGS PER SHARE | ||||||
| Basic EPS (Rs.) | -1.00 | 0.00 | -5.00 | 176.00 | -24.00 | |
| Diluted EPS (Rs.) | -1.00 | 0.00 | -5.00 | 176.00 | -24.00 | |
| DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
| Equity Share Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
26.12.2025
16.12.2025
27.11.2025
26.11.2025
Panacea Biotec Consolidated September 2025 Net Sales at Rs 141.13 crore, down 4.22% Y-o-Y
26.11.2025
Panacea Biotec Consolidated September 2025 Net Sales at Rs 141.13 crore, down 4.22% Y-o-Y
24.11.2025
Panacea Biotec Standalone September 2025 Net Sales at Rs 90.81 crore, up 18.49% Y-o-Y
11.06.2025
Panacea Biotec Standalone March 2025 Net Sales at Rs 67.90 crore, down 15.52% Y-o-Y
03.06.2025
Panacea Biotec Consolidated March 2025 Net Sales at Rs 132.53 crore, down 2.88% Y-o-Y